207 related articles for article (PubMed ID: 1388318)
1. Suppression of the Arthus reaction by Y-24180, a potent and specific antagonist of platelet-activating factor.
Okamoto H; Iwahisa Y; Terasawa M
Agents Actions; 1992 Mar; 35(3-4):149-58. PubMed ID: 1388318
[TBL] [Abstract][Full Text] [Related]
2. Effect of Y-24180, a platelet-activating factor-receptor antagonist, on the antigen-induced airway microvascular leakage in guinea pigs.
Iwahisa Y; Yamaguchi S; Kagoshima M; Terasawa M
Jpn J Pharmacol; 1996 Nov; 72(3):209-15. PubMed ID: 8957681
[TBL] [Abstract][Full Text] [Related]
3. Effect of Y-24180, a long-acting antagonist to platelet-activating factor (PAF), on PAF-induced reactions: a relationship between the partial structure of the compound and its duration of the action.
Kagoshima M; Tomomatsu N; Iwahisa Y; Yamaguchi S; Kawakami Y; Terasawa M
Pharmacology; 1997 May; 54(5):261-70. PubMed ID: 9380772
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological actions of Y-24180: I. A potent and specific antagonist of platelet-activating factor.
Terasawa M; Aratani H; Setoguchi M; Tahara T
Prostaglandins; 1990 Dec; 40(6):553-69. PubMed ID: 2093935
[TBL] [Abstract][Full Text] [Related]
5. Pharmacologic activity of bepafant (WEB 2170), a new and selective hetrazepinoic antagonist of platelet activating factor.
Heuer HO; Casals-Stenzel J; Muacevic G; Weber KH
J Pharmacol Exp Ther; 1990 Dec; 255(3):962-8. PubMed ID: 2262914
[TBL] [Abstract][Full Text] [Related]
6. A specific antagonist of platelet-activating factor suppresses oedema formation in an Arthus reaction but not oedema induced by leukocyte chemoattractants in rabbit skin.
Hellewell PG; Williams TJ
J Immunol; 1986 Jul; 137(1):302-7. PubMed ID: 2940300
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological actions of Y-24180, a new specific antagonist of platelet activating factor (PAF): II. Interactions with PAF and benzodiazepine receptors.
Takehara S; Mikashima H; Muramoto Y; Terasawa M; Setoguchi M; Tahara T
Prostaglandins; 1990 Dec; 40(6):571-83. PubMed ID: 1965554
[TBL] [Abstract][Full Text] [Related]
8. Studies on the mechanisms involved in the inflammatory response in a reversed passive Arthus reaction in guinea-pig skin: contribution of neutrophils and endogenous mediators.
Teixeira MM; Fairbairn SM; Norman KE; Williams TJ; Rossi AG; Hellewell PG
Br J Pharmacol; 1994 Dec; 113(4):1363-71. PubMed ID: 7889293
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological activities of a novel thienodiazepine derivative as a platelet-activating factor antagonist. Effects on microvascular permeability, hypotension and nephrosis.
Sakuma Y; Shirato M; Nagaoka J; Obaishi H; Tsunoda H; Katayama S; Ono H; Katayama K
Arzneimittelforschung; 1991 Dec; 41(12):1255-9. PubMed ID: 1815526
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological actions of WEB 2086, a new specific antagonist of platelet activating factor.
Casals-Stenzel J; Muacevic G; Weber KH
J Pharmacol Exp Ther; 1987 Jun; 241(3):974-81. PubMed ID: 3598913
[TBL] [Abstract][Full Text] [Related]
11. Evidence that platelet activating factor may mediate some acute inflammatory responses. Studies with the platelet-activating factor antagonist, CV3988.
Issekutz AC; Szpejda M
Lab Invest; 1986 Mar; 54(3):275-81. PubMed ID: 3951199
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of leukocyte adhesion to endothelial cells of human umbilical vein by Y-24180, an antagonist of platelet-activating factor.
Komatsu H; Nagasawa M; Okumoto T
Int J Immunopharmacol; 1993 Aug; 15(6):737-44. PubMed ID: 7691768
[TBL] [Abstract][Full Text] [Related]
13. The role of complement, platelet-activating factor and leukotriene B4 in a reversed passive Arthus reaction.
Rossi AG; Norman KE; Donigi-Gale D; Shoupe TS; Edwards R; Williams TJ
Br J Pharmacol; 1992 Sep; 107(1):44-9. PubMed ID: 1330163
[TBL] [Abstract][Full Text] [Related]
14. Effect of a Paf antagonist, WEB 2086, on airway microvascular leakage in the guinea-pig and platelet aggregation in man.
Evans TW; Dent G; Rogers DF; Aursudkij B; Chung KF; Barnes PJ
Br J Pharmacol; 1988 May; 94(1):164-8. PubMed ID: 3401633
[TBL] [Abstract][Full Text] [Related]
15. Role of platelet-activating factor (PAF) in platelet accumulation in rabbit skin: effect of the novel long-acting PAF antagonist, UK-74,505.
Pons F; Rossi AG; Norman KE; Williams TJ; Nourshargh S
Br J Pharmacol; 1993 May; 109(1):234-42. PubMed ID: 8495241
[TBL] [Abstract][Full Text] [Related]
16. Inhibitor effect of apafant on bronchopulmonary responses to platelet activating factor and to antigen in rats.
Akagi M; Nishioka E; Kanoh R; Tachibana M; Fukuishi N
Arzneimittelforschung; 1997 Dec; 47(12):1364-9. PubMed ID: 9450165
[TBL] [Abstract][Full Text] [Related]
17. Histamine, leukotriene D4 and platelet-activating factor in guinea pig passive cutaneous anaphylaxis.
Weg VB; Watson ML; Cordeiro RS; Williams TJ
Eur J Pharmacol; 1991 Nov; 204(2):157-63. PubMed ID: 1687219
[TBL] [Abstract][Full Text] [Related]
18. Platelet-activating factor mediates the ozone-induced increase in airway microvascular leakage in guinea pigs.
Kaneko T; Ikeda H; Fu L; Nishiyama H; Okubo T
Eur J Pharmacol; 1995 Mar; 292(3-4):251-5. PubMed ID: 7796863
[TBL] [Abstract][Full Text] [Related]
19. Pharmacology of a potent platelet-activating factor antagonist: Ro 24-4736.
Crowley HJ; Yaremko B; Selig WM; Janero DR; Burghardt C; Welton AF; O'Donnell M
J Pharmacol Exp Ther; 1991 Oct; 259(1):78-85. PubMed ID: 1656030
[TBL] [Abstract][Full Text] [Related]
20. Anti-anaphylactic activity of the novel selective histamine H1 receptor antagonist mizolastine in the rodent.
Levrier J; Duval D; Prouteau M; Voltz C; Berry CN; Lloyd KG; Scatton B
Arzneimittelforschung; 1995 May; 45(5):559-68. PubMed ID: 7541995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]